NFA
ECYT

Nationwide Fund Advisors’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Nationwide Fund Advisors’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-29,221
Closed -$44K – 3220
2017
Q2 		$44K Buy
29,221
+8,270
+39% +$17.8K ﹤0.01% 3067
2017
Q1 		$54K Sell
20,951
-25,877
-55% -$59.9K ﹤0.01% 2972
2016
Q4 		$119K Buy
46,828
+21,400
+84% +$61.4K ﹤0.01% 2815
2016
Q3 		$79K Sell
25,428
-7,989
-24% -$24.9K ﹤0.01% 2969
2016
Q2 		$107K Buy
33,417
+7,989
+31% +$29.3K ﹤0.01% 2884
2016
Q1 		$79K Hold
25,428
– – ﹤0.01% 2888
2015
Q4 		$102K Sell
25,428
-31,000
-55% -$143K ﹤0.01% 2841
2015
Q3 		$258K Hold
56,428
– – ﹤0.01% 2442
2015
Q2 		$293K Sell
56,428
-1,884
-3% -$11.3K ﹤0.01% 2519
2015
Q1 		$365K Buy
58,312
+13,387
+30% +$77.3K ﹤0.01% 2405
2014
Q4 		$283K Hold
44,925
– – ﹤0.01% 2481
2014
Q3 		$273K Buy
44,925
+389
+0.9% +$2.66K ﹤0.01% 2542
2014
Q2 		$293K Buy
44,536
+12,094
+37% +$136K ﹤0.01% 2542
2014
Q1 		$772K Sell
32,442
-261
-0.8% -$3.78K ﹤0.01% 1860
2013
Q4 		$350K Sell
32,703
-575
-2% -$6.35K ﹤0.01% 2408
2013
Q3 		$444K Buy
33,278
+10,555
+46% +$167K ﹤0.01% 2283
2013
Q2 		$298K Buy
+22,723
New +$306K ﹤0.01% 2302

Other funds holding ECYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nationwide Fund Advisors's ECYT Position: Q3 2017 in Review

Nationwide Fund Advisors sold out of Endocyte, Inc. Common Stock (ECYT) in Q3 2017, closing a stake of 29,221 shares — an estimated $44K sold.

Nationwide Fund Advisors first reported a position in ECYT in Q2 2013 and held it in 17 quarters. The position peaked at $772K in Q1 2014. 63 funds tracked by Wall St. Rank hold ECYT as of Q3 2017.

  • Nationwide Fund Advisors reported no remaining Endocyte, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 29,221 Endocyte, Inc. Common Stock shares in Q3 2017, an estimated $44K.
  • Nationwide Fund Advisors first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 17 quarters.
  • Nationwide Fund Advisors's Endocyte, Inc. Common Stock position peaked at $772K in Q1 2014.
  • 63 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q3 2017.

Based on Nationwide Fund Advisors's 13F filing for Q3 2017, filed 23 Oct 2017.